Menopause
From the Journals
Premature menopause a ‘warning sign’ for greater ASCVD risk
Clinical Review
2021 Update on female sexual health
Data on recent studies related to CO2 laser therapy and female sexual function plus a peer-to-peer discussion on laser safety, efficacy, and...
Opinion
Grandmothers, the Friendship Bench, and wisdom
The method has been empirically vetted and expanded to countries beyond, including the United States, said Dr. Alison M. Heru.
From the Editor
3 cases of hormone therapy optimized to match the patient problem
There are 5 different dose combinations of ethinyl estradiol and norethindrone acetate, ranging from 2.5 µg to 30 µg of ethinyl estradiol, and a...
Latest News
Hormone pellet safety data ‘not very reassuring at all’ for women
Patients receiving compounded pellet hormonal therapy had higher rates of abnormal uterine bleeding and hysterectomy, compared with patients on...
Conference Coverage
Pilot study: Hybrid laser found effective for treating genitourinary syndrome of menopause
Further studies are important to improve the understanding of "laser dosimetry, frequency of treatments, and longevity of effect.
Conference Coverage
Primary ovarian insufficiency requires long-term management of sequelae
It’s important that clinicians not only consider the potential cardiovascular risks associated with early menopause but also the risks to bone...
Product Review
FDA and power morcellation, gel for vaginal odor, and an intrauterine electrosurgery system
FDA and power morcellation, gel for vaginal odor, and an intrauterine electrosurgery system
FDA guidance for...
Latest News
Pregnancy after pioneering treatment for early menopause
"Although [the means] are considered experimental, we demonstrated the restoration of ovarian function in early menopausal women who adopted whole...
Conference Coverage
Can supplementary estrogen relieve MS symptoms in menopausal women?
Research suggests lowered hormone levels may worsen the disease.
From the Journals
Menopause transition affects heart health risks
Consensus statement offers considerations for postmenopausal cardiovascular disease prevention.